Welsh renewable energy company Dulas, supported by UK Export Finance and HSBC UK, is delivering solar-powered vaccine refrigerators to over 80 countries, showcasing Britain’s leadership in global immunisation.
This initiative supports UK manufacturing jobs and highlights the importance of government-backed finance in managing global demand for vaccine storage solutions.
UK Manufacturing Leadership
Dulas stands out as the only UK manufacturer of World Health Organisation-accredited off-grid solar-powered vaccine refrigerators.
This achievement not only underscores the UK’s prowess in manufacturing but also highlights its commitment to supporting global health initiatives.
The company’s products are crucial for maintaining vaccine efficacy in remote regions lacking reliable electricity.
Government Support and Economic Benefits
The collaboration between UK Export Finance and HSBC UK has been instrumental since 2022, providing annual finance packages that help Dulas manage unpredictable demand while maintaining production.
This support ensures job security for around 100 staff across Wales, Scotland, and West Sussex, reinforcing the economic benefits of such initiatives.
Global Impact and Innovation
Dulas’s solar-powered fridges have reached over 80 countries, including conflict zones and disaster areas.
This global reach not only supports immunisation efforts but also advances renewable energy adoption in developing regions.
By combining healthcare with sustainable technology, Dulas addresses both climate challenges and public health needs.
Challenges Ahead
- Managing fluctuating international demand due to conflicts or natural disasters
- Navigating potential reductions in UK aid budgets affecting humanitarian exports
- Sustaining innovation through continued investment in research and development
Industry Perspectives
Ruth Chapman, Executive Managing Director of Dulas Ltd., praised the General Export Facility (GEF) for its role in supporting their export business amidst challenging conditions.
She emphasized the pride in manufacturing within the UK while contributing to global efforts against common childhood illnesses.
“The GEF facility has been an invaluable tool for our export business,” said Ruth Chapman. “We are very proud to manufacture our products within the UK and contribute towards global efforts to eradicate common childhood illnesses.”
Additional Reading
Wrapping Up
Dulas’s achievements highlight how government-backed finance can bolster British innovation on a global scale.
As they continue to deliver life-saving technology worldwide, sustained support will be crucial for navigating future challenges and ensuring that British expertise remains at the forefront of international health solutions.
Sources: UK Government, Dulas Ltd, UK Export Finance, Department for Business and Trade and Wales Office.
Prepared by Ivan Alexander Golden, Founder of THX News™, an independent news organization delivering timely insights from global official sources. Combines AI-analyzed research with human-edited accuracy and context.
